📰 Forward Looking News
Page 27 - Forward Looking News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking. Real-time updates on events, politics, business and more.
January 24, 2023
To view a summary of today's press release by Ridgeline CEO Chad Peters, click HERE Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Ridgeline Minerals Corp. (TSXV: RDG) (OTCQB: RDGMF)
January 19, 2023
December 2022 Highlights (in USD):Confirmed Customer Orders: $5,683,527.Confirmed Sales Orders: 224.New Customer Conversions: 53.Total Throughput: 23,956,748 cans.Decoration Throughput: 2,987,095 cans.Filling
January 19, 2023
Investegate announcements from Marble Point Ln Fin, Dividend Declaration
January 17, 2023
VANCOUVER, BC / ACCESSWIRE / January 17, 2023 / Faraday Copper Corp. (" Faraday " or the " Company ") (TSX:FDY)(OTCQX:CPPKF) is pleased to announce the results from two drill holes at its Copper Creek
January 10, 2023
TORONTO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) ("DPM" or "the Company") announced preliminary production results from both of its mines in Bulgaria and the Tsumeb smelter
January 10, 2023
VANCOUVER, BC / ACCESSWIRE / January 10, 2023 / Faraday Copper Corp. ("Faraday" or the "Company") (TSX:FDY)(OTCQX:CPPKF) is pleased to provide an exploration update at its Copper Creek project in Arizona
January 8, 2023
TORONTO, ON / ACCESSWIRE / January 7, 2023 / EonX Technologies Inc. (CSE:EONX), ("EonX" or the "Company") has secured a loan facility for $7,300,000 AUD ($6,730,000 CAD), to be used for working capital
January 7, 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency - read this article along with other careers information, tips and advice on BioSpace
January 4, 2023
/PRNewswire/ -- NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for...
January 3, 2023
Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022SINGAPORE, Jan. 03, 2023 (Tessa), a clinical-stage cell therapy company developing